1,320 HVAD™ patients on support worldwide as of Q4FY25
Source: HVAD™ site reported data, April 2025. Not independently confirmed or validated by Medtronic.
Underlying data provided with the permission of The Society of Thoracic Surgeons.
Copyright © 2024 The Society of Thoracic Surgeons.
1. Subjects were censored at the time of any non-death related explant.
2. Contemporary cohort was stratified by year-of-implant following FDA approval of the HVAD System for Destination Therapy (October 2017) through cessation of the sale and distribution of the device (June 2021): October-December 2017, 2018, 2019, 2020, January–June 2021.
3. STS Intermacs Report – North American registry data of FDA-approved durable devices implanted for treatment of advanced heart failure; current analysis is for fourth quarter 2024 with follow-up through 31 December 2024.
STS — Society of Thoracic Surgeons; Intermacs — Interagency Registry of Mechanically Assisted Circulatory Support; FDA — Food and Drug Administration.
